Antitumour effect of polyoxomolybdates
Author Information
Author(s): Ogata A, Yanagie H, Ishikawa E, Morishita Y, Mitsui S, Yamashita A, Hasumi K, Takamoto S, Yamase T, Eriguchi M
Primary Institution: Tokyo Institute of Technology
Hypothesis
Does polyoxomolybdate PM-17 induce apoptotic cell death and autophagy in pancreatic and gastric cancer cells?
Conclusion
PM-17 shows significant antitumour activity by inducing both apoptosis and autophagy in pancreatic cancer cells.
Supporting Evidence
- PM-17 inhibited the growth of human pancreatic cancer xenografts in a nude mice model.
- PM-17 induced morphological alterations in tumour cells.
- The study observed apoptotic patterns and autophagic features in treated cells.
Takeaway
A special compound called PM-17 can help fight pancreatic cancer by making cancer cells die in two ways: by a process called apoptosis and another called autophagy.
Methodology
The study involved in vitro and in vivo tests on cancer cell lines and xenografts, assessing cell viability, apoptosis, and autophagy.
Limitations
The study primarily focused on specific cancer cell lines and may not represent all types of pancreatic cancer.
Participant Demographics
Female nude mice were used for in vivo experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website